Forget injections. A new drug promises to be just as effective as Ozempic — but is taken as a daily pill. Called orforglipron, the results of a new clinical trial announced Thursday by ...

The jab averse can now rejoice! Drug manufacturer Eli Lilly announced this week that an encouraging clinical trial of their new pill promises a convenient, stab-free way to treat diabetes and obesity.

When taken for 40 weeks for type 2 diabetes, orforglipron resulted in an average loss of 16 pounds, or about 7.9% of the patient's body weight, at the highest dose. HealthDay News — A new pill ...

Investing.com -- Novo Nordisk (NYSE:NVO) shares sank more than 7% in Copenhagen after Eli Lilly (NYSE:LLY) released promising trial results for its experimental obesity pill, orforglipron ...

Faulty LED streetlights have been turning purple for years across America. As the lights fail, many are replaced. That has led to years of purple streetlights that seemingly appear and then ...

We may earn commission if you buy from a link. Why Trust Us? The human eye does not actually see purple, as purple is not a color on the visual spectrum. Purple is a combination of wavelengths ...

UNITED STATES – Pfizer is ending the development of its potential once-daily pill treatment for obesity after venturing into the biggest and most expensive level of clinical testing. The ...

As with the advent of new technologies, new problems arise and virtual “pill mills” stand to be one of the greatest complications as they abuse the loopholes created from telehealth platforms ...

TSMC reported net sales up 35.3% Y/Y to $25.53B (NT$839.25B), missing estimates and declining 5.1% sequentially from $26.88B last quarter. For Q2, management is guiding for sales between $28.4B to ...

Gujarat Titans’ Sai Sudharsan celebrates his half century against Kolkata Knight Riders in IPL 2025 at Eden Gardens in Kolkata on Monday. (ANI) Sai Sudharsan toppled Lucknow Super Giants (LSG ...

New research released Thursday morning shows a new, oral GLP-1 pill may be just as beneficial to those with Type 2 diabetes as injectable GLP-1 drugs. Drugmaker Eli Lilly said that in Phase 3 ...